Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 94 of the 94 references it cites were found in a registry or an index.

Vascular cognitive impairment

Abstract

Cerebrovascular disease is the second most common cause of acquired cognitive impairment and dementia and contributes to cognitive decline in the neurodegenerative dementias. The current narrow definitions of vascular dementia should be broadened to recognise the important part cerebrovascular disease plays in several cognitive disorders, including the hereditary vascular dementias, multi-infarct dementia, post-stroke dementia, subcortical ischaemic vascular disease and dementia, mild cognitive impairment, and degenerative dementias (including Alzheimer's disease, frontotemporal dementia, and dementia with Lewy bodies). Here we review the current state of scientific knowledge on the subject of vascular brain burden. Important non-cognitive features include depression, apathy, and psychosis. We propose use of the term vascular cognitive impairment, which is characterised by a specific cognitive profile involving preserved memory with impairments in attentional and executive functioning. Diagnostic criteria have been proposed for some subtypes of vascular cognitive impairment, and there is a pressing need to validate and further refine these. Clinical trials in vascular cognitive impairment are in their infancy but support the value of therapeutic interventions for symptomatic treatment.

Overview

Integrity signals

Registry

Crossref · 10.1016/s1474-4422(03)00305-3

Cites

94 of 94 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

3 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Citations

Cites

Show all 92 references

Research works printed but not linked: 7

  1. Hachinski, 1974, When vascular disease is responsible for dementia it is through the occurrence of multiple small or large cerebral infarcts, Lancet, 2, 207, 10.1016/s0140-6736(74)91496-2 · DOI · Paper page
  2. Premkumar, 1996, Apolipoprotein E e4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology in Alzheimer's disease, Am J Pathol, 148, 2083
  3. Roman, 1993, Vascular dementia: diagnostic criteria for research studies: report of the NINDS-AIREN international workshop, Neurology, 43, 250, 10.1212/wnl.43.2.250 · DOI · Paper page
  4. Orgogozo J-M, Rigaud A-S, Stöffler A, Möbius H-J, Forette F. Efficacy and safety of Mementaine in patients with mild to moderate vascular dementia: a randomised, placebo-controlled trial (MMM 300). Stroke (in press).
  5. Lopez-Arrieta BJ. Nimodipine for primary degenerative, mixed and vascular dementia (Cochrane Review). Cochrane Database Syst Rev 2001;1:CD000147.
  6. Erkinjuntti, 2002, Galantamine is efficacious in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease, Lancet, 329, 1283, 10.1016/s0140-6736(02)08267-3 · DOI · Paper page
  7. Tarrier N, Ward J, Burns A, Donaldson C, Barrowclough C. Expressed emotion and attributes in the carers of patients with Alzheimer's disease: the effect on carer burden. J Abnorm Psychol (in press).

Cited by

See all 1,139

Metadata

Authors
O'Brien, J. T., Erkinjuntti, T., Reisberg, B., Roman, G., Sawada, T., Pantoni, L., Bowler, J. V., Ballard, C., DeCarli, C., Gorelick, P. B., Rockwood, K., Burns, A., Gauthier, S., & DeKosky, S. T.
Affiliations
  • Newcastle upon Tyne Hospital (GB)
  • Helsinki University Hospital (FI)
  • NYU Langone Health (US)
  • The University of Texas at San Antonio Health Science Center (US)
  • University of Florence (IT)
  • The Royal Free Hospital (GB)
  • University of California, Davis (US)
  • Rush University Medical Center (US)
  • Dalhousie University (CA)
  • University of Manchester (GB)
  • McGill University (CA)
  • University of Pittsburgh (US)
Corresponding author
O'Brien, John T
Venue
The Lancet Neurology
Publisher
Elsevier BV
Published
2003-02
Volume
2
Issue
2
Pages
89-98
ISSN
1474-4422 (ISSN-L)
OpenAlex
W4210993281
Cited by
1,139
References
92
Citations by year
2026: 19 · 2025: 35 · 2024: 38 · 2023: 39 · 2022: 51 · 2021: 62 · 2020: 91 · 2019: 58 · 2018: 47 · 2017: 61 · 2016: 54 · 2015: 53 · 2014: 63 · 2013: 46 · 2012: 59
FWCI
6.21
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • The Lancet Neurology (publishedVersion)
  • Research Explorer (The University of Manchester) (submittedVersion)
Funders
  • European Commission
  • National Institute of Neurological Disorders and Stroke (R01NS017950)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
  • Health Sciences › Medicine › Clinical Neurology › Cerebrovascular and genetic disorders
Keywords
vascular cognitive impairment, cerebrovascular disease, dementia, mild cognitive impairment, multi-infarct dementia, post-stroke dementia, Alzheimer's disease, frontotemporal dementia, dementia with Lewy bodies, executive dysfunction, attentional impairment, depression, apathy, psychosis, diagnostic criteria

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Vascular cognitive impairment. https://app.cochat.ai/papers/10.1016/s1474-4422(03)00305-3
The paper
O'Brien, J. T., Erkinjuntti, T., Reisberg, B., Roman, G., Sawada, T., Pantoni, L., Bowler, J. V., Ballard, C., DeCarli, C., Gorelick, P. B., Rockwood, K., Burns, A., Gauthier, S., & DeKosky, S. T. (2003). Vascular cognitive impairment. The Lancet Neurology. https://doi.org/10.1016/s1474-4422(03)00305-3

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.